Lazari Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $846K | Sell |
18,282
-167
| -0.9% | -$7.73K | 0.32% | 52 |
|
|
2025
Q1 | $1.13M | Sell |
18,449
-1,965
| -10% | -$120K | 0.46% | 41 |
|
|
2024
Q4 | $1.15M | Sell |
20,414
-2,076
| -9% | -$117K | 0.46% | 35 |
|
|
2024
Q3 | $1.16M | Sell |
22,490
-673
| -3% | -$34.8K | 0.5% | 37 |
|
|
2024
Q2 | $962K | Sell |
23,163
-1,535
| -6% | -$63.7K | 0.43% | 41 |
|
|
2024
Q1 | $1.34M | Sell |
24,698
-1,058
| -4% | -$57.4K | 0.73% | 28 |
|
|
2023
Q4 | $1.32M | Sell |
25,756
-570
| -2% | -$29.2K | 0.76% | 27 |
|
|
2023
Q3 | $1.53M | Sell |
26,326
-4,800
| -15% | -$279K | 0.91% | 24 |
|
|
2023
Q2 | $1.99M | Buy |
+31,126
| New | +$1.99M | 1.12% | 18 |
|